Avalon GloboCare Receives Notice from Nasdaq Regarding Delayed Quarterly Report
The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.
- The Notice has no immediate effect on the listing or trading of the Company’s common stock on the Nasdaq Capital Market.
- If Nasdaq accepts the Company’s plan to regain compliance, then Nasdaq may grant the Company up to 180 calendar days from the prescribed due date of the Quarterly Report, or November 18, 2024, to file the Quarterly Report to regain compliance.
- The Company continues to work diligently to finalize its Quarterly Report and plans to file its Quarterly Report as promptly as possible to regain compliance with the Listing Rule.
- This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.